3-Amino-1-(3-trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluoro-phenyl)-but-2-en-1-one 767340-03-4 98%

Actis Generics Pvt Ltd is a fast emerging APIs (Active Pharmaceutical Ingredients) & Intermediates manufacturer & supplier in India set up by a group of young professionals with the specific objective of providing the critical India advantage to both the innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets.
The paradigm shift of leading Indian pharmaceutical companies to target high volume and blockbuster products for regulated markets has been the inspiration behind the launch of Actis Pharma. We undertake both contract research and manufacturing to meet the APIs needs of pharmaceutical and bulk drugs manufacturers.
As a leading pharmaceutical APIs & Intermediates manufacturer and supplier, Actis Pharma’s mission is to develop and produce complex, small & big volume, technology driven products required by the generic industry, thus filling in the gap left by the large Indian pharma companies. Value creation for our customers is at the core of what we do. We achieve this through partnership with our customers and supporting them in meeting their goals in terms of quality, time and costs.
Based in Visakhapatnam, the pharma hub of India, we have made our presence felt in the highly competitive field of APIs and Intermediates, by offering customers the highest quality, cost-competitive products with a short development time.